deltatrials
Completed PHASE2 NCT00220779

Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis

Randomized, Double-Blind, Placebo-Controlled Study to Compare the Effects of Different Dose Regimens of IGIV Chromatography (IGIV-C), 10% Treatment on Relapses in Patients With Relapsing Remitting Multiple Sclerosis

Sponsor: Grifols Therapeutics LLC

Conditions Multiple Sclerosis, Relapsing-Remitting
Interventions Albumin (Human) 25%, United States Pharmacopeia (USP) Immune Globulin IV [Human], 10% Caprylate/Chromatography Purified
Updated 8 times since 2017 Last updated: Mar 28, 2016 Started: Dec 31, 2002 Primary completion: Feb 28, 2005 Completion: Feb 28, 2005

This PHASE2 trial investigates Multiple Sclerosis, Relapsing-Remitting and is currently completed. Grifols Therapeutics LLC leads this study, which shows 8 recorded versions since 2002 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

8 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

▶ Show 3 earlier versions

  1. Apr 2018 — Jun 2018 [monthly]

    Completed PHASE2

  2. Feb 2017 — Apr 2018 [monthly]

    Completed PHASE2

  3. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE2

    First recorded

Dec 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Grifols Therapeutics LLC
Data source: Grifols Therapeutics LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Athens, Greece, Bratislava, Slovakia, Brno, Czechia, Budapest, Hungary, Burlington, United States, Calgary, Canada, Düsseldorf, Germany, Erfurt, Germany, Giessen, Germany, Graz, Austria and 22 more location s